Article Text

Download PDFPDF
Effect of the Smoke-Free Illinois Act on casino admissions and revenue
  1. John A Tauras1,
  2. Frank J Chaloupka1,
  3. Gregg Moor2,
  4. Patricia Nez Henderson3,
  5. Scott J Leischow4
  1. 1 Department of Economics, University of Illinois at Chicago and NBER, Chicago, Illinois, USA
  2. 2 InSource, Coquitlam, British Columbia, Canada
  3. 3 Black Hills Center for American Indian Health, Rapid City, South Dakota, USA
  4. 4 Mayo Clinic, Scottsdale, Arizona, USA
  1. Correspondence to Dr John A Tauras, Department of Economics, University of Illinois at Chicago and NBER, Chicago, IL 60607-7121, USA; tauras{at}


Objective As part of the Smoke-Free Illinois Act, smoking on the gambling floors of all commercial casinos in Illinois became prohibited. This study examined the effects of the Smoke-Free Illinois Act on casino admissions per-capita and real per-capita adjusted gross receipts using 18 years of data (10 years before and 8 years after the Illinois law went into effect).

Methods We employed a difference-in-difference regression technique using monthly data for the states of Illinois, Indiana, Iowa and Missouri and control for numerous determinants expected to affect casino admissions and revenue.

Results The Smoke-free Illinois Act was found not to be a statistically significant determinant of per-capita casino admissions and of real per-capita gross adjusted receipts in all the models we estimated.

Conclusions The estimates from this study clearly indicated that the Illinois law that banned smoking in casinos has had no significant negative economic consequences for casinos in terms of per-capita admissions or revenues.

  • economics
  • public policy
  • secondhand smoke

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors JAT was the primary writer of the article and participated in the study design, statistical analysis and interpretation of the data. FJC and SJL participated in the study design, interpretation of the data and writing parts of the article. GM and PNH participated in interpreting the data and reviewing drafts of the article.

  • Funding This research was funded by 5U01CA154300-05 from the National Cancer Institute (PI SJL, PhD).

  • Disclaimer All views expressed are those of the authors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.